DSPE-PEG 2000 is a lipid-polymer conjugate used to form stable micelles for drug delivery, with the PEG head group enhancing biocompatibility and circulation time. The micelles undergo a phase transition at 12°C, from a glassy to a fluid phase, affecting stability and monomer desorption rates. The size of the PEG chain and lipid tail influence […]

DSPE-PEG 2000 is a lipid-polymer conjugate used to form stable micelles for drug delivery, with the PEG head group enhancing biocompatibility and circulation time. The micelles undergo a phase transition at 12°C, from a glassy to a fluid phase, affecting stability and monomer desorption rates. The size of the PEG chain and lipid tail influence […]

DSPE-PEG 2000 is a lipid-polymer conjugate used to form stable micelles for drug delivery, with the PEG head group enhancing biocompatibility and circulation time. The micelles undergo a phase transition at 12°C, from a glassy to a fluid phase, affecting stability and monomer desorption rates. The size of the PEG chain and lipid tail influence […]

ATX968 (DHX9-IN-2) is a potent, selective, and orally bioavailable inhibitor of DHX9 helicase with an IC50 of 8 nM. It induces strong and sustained tumor growth inhibition or regression in MSI-H/dMMR colorectal cancer (CRC) xenograft models.

ATX968 (DHX9-IN-2) is a potent, selective, and orally bioavailable inhibitor of DHX9 helicase with an IC50 of 8 nM. It induces strong and sustained tumor growth inhibition or regression in MSI-H/dMMR colorectal cancer (CRC) xenograft models.

Heparin is a highly sulfated polysaccharide primarily used as an anticoagulant, which works mainly by inhibiting thrombin (FIIa) and/or factor Xa (FXa). It is commonly used to prevent and treat thromboembolic conditions such as deep vein thrombosis and pulmonary embolism. It also plays roles in inflammation, angiogenesis, and growth factor signaling, with potential therapeutic applications […]

ATX968 (DHX9-IN-2) is a potent, selective, and orally bioavailable inhibitor of DHX9 helicase with an IC50 of 8 nM. It induces strong and sustained tumor growth inhibition or regression in MSI-H/dMMR colorectal cancer (CRC) xenograft models.

ATX968 (DHX9-IN-2) is a potent, selective, and orally bioavailable inhibitor of DHX9 helicase with an IC50 of 8 nM. It induces strong and sustained tumor growth inhibition or regression in MSI-H/dMMR colorectal cancer (CRC) xenograft models.

Heparin is a highly sulfated polysaccharide primarily used as an anticoagulant, which works mainly by inhibiting thrombin (FIIa) and/or factor Xa (FXa). It is commonly used to prevent and treat thromboembolic conditions such as deep vein thrombosis and pulmonary embolism. It also plays roles in inflammation, angiogenesis, and growth factor signaling, with potential therapeutic applications […]

Heparin is a highly sulfated polysaccharide primarily used as an anticoagulant, which works mainly by inhibiting thrombin (FIIa) and/or factor Xa (FXa). It is commonly used to prevent and treat thromboembolic conditions such as deep vein thrombosis and pulmonary embolism. It also plays roles in inflammation, angiogenesis, and growth factor signaling, with potential therapeutic applications […]